drugset / Trial / NCT07071974
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate relative bioavailability of BI 456906 reference formulation (Formulation A) vs. BI 456906 test formulation (Formulation B2).
Timeline
- Start
- 2025-07-28
- Primary completion
- 2025-10-07
- Completion
- 2025-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Survodutide | Protein / enzyme biologic | — | Subcutaneous |
Indications
No indication recorded.